@eurordis.bsky.social🇪🇺 How can rare disease research become part of routine care?
Join “Research as Care” in Dublin on 13 November to explore the #BiotechAct, patient partnerships and an EU Action Plan on Rare Diseases.
📍 Dublin | 13 Nov 👉 Register: https://go.eurordis.org/rare-diseases-event
@sipri.orgThe EU has resumed work to finalize legislation aimed at regulating access to synthetic genetic material that could be used to produce biological weapons.
In this Q&A, Dr Miranda Smith answers questions about the European Biotech Act.
Read it now ➡️ www.sipri.org/commentary/t...
@eurordis.bsky.socialToday at the European Parliament, an expert dialogue on the #BiotechAct explored how to strengthen clinical research, support non-profit innovation and improve access to treatments.
The call: an inclusive biotech ecosystem and an EU Action Plan on Rare Diseases. 👉 https://go.eurordis.org/Intergroup
@eurordis.bsky.social🧬 Today at the European Parliament!
How can the #BiotechAct boost research and improve access to treatments for cancer and rare disease patients?
🔴 Follow the expert dialogue LIVE!
🕒 15:45–17:30 CEST
👉 https://go.eurordis.org/ExpertDialogueLivestream
@erc.europa.euToday’s discoveries can become tomorrow’s possibilities.
In a new ERC report, Dirk Inzé and Geneviève Almouzni reflect on how curiosity-driven research in #biotechnology can open new avenues towards innovation.
